US manufacturers are increasingly nervous about President Trump’s tariffs. They’re already disrupting supply chains, and the ...

Despite expansion in manufacturing activities, slowdown in new orders and supply-chain issues amid tariff-related risks have ...

A bearish outlook, weak technicals, and speculative fundamentals lead to a sell rating for NuScale (SMR) stock amidst a ...

The U.S. stock market is struggling to find stability amid shifting economic policies, trade tensions, and concerns about ...

Q4 2024 Earnings Call Transcript March 27, 2025 BK Technologies Corporation beats earnings expectations. Reported EPS is ...

Gains beyond 1.0855 expose the 1.0900 region, while beyond the latter, EUR/USD could extend gains towards the 1.1000 mark. On the contrary, a slide below 1.0730 exposes the 1.0630 area, with the next ...

In early trade on Friday, these stocks dropped by as much as 3%, with the Nifty Auto and Nifty Pharma indices trading lower ...

BEML stock shows growth potential, with expert targeting ₹3800-4200. The PSU company shares Surge 7% following a ₹405 crore ...

Commonwealth Equity Services LLC cut its position in XPO, Inc. (NYSE:XPO – Free Report) by 1.6% during the 4th quarter, ...

Second AirSCWO Deploying to Orange County, CA in 2025, Multiple Additional Deployments Scheduled throughout 2025 to Showcase AirSCWO Successful Demonstrations in Collaboration with Municipal and Feder ...

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first ...

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent ...